Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM

Nicola Abate, Gloria Lena Vega, Abhimanyu Garg, Scott M. Grundy

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

This study was carried out to identify and define lipoprotein abnormalities in patients with noninsulin-dependent diabetes mellitus (NIDDM) who do not have clinical elevations of cholesterol or triglycerides. Thirty-four male patients with mild NIDDM and normolipidemia (plasma cholesterol ≤ 240 mg/dl and triglycerides ≤ 250 mg/dl) were compared with 35 healthy male normolipidemic subjects. The two groups had similar age and body mass index. Measurements in the two groups included concentrations and chemical composition of lipoproteins and sizing of low-density lipoprotein (LDL) particles. The patients with NIDDM, compared to control subjects, had two distinct lipoprotein abnormalities: first, a significantly reduced level of high-density lipoprotein (HDL) cholesterol (mean ± S.D., 35 ± 8 mg/dl vs. 41 ± 10 mg/dl, respectively; P = 0.006); and second, a high cholesterol-to-apolipoprotein (apo) B ratio both in very low density lipoprotein (VLDL) + intermediate density lipoprotein (IDL) fraction (mean ± S.D.; 3.2 ± 0.8 vs. 2.8 ± 0.9, respectively; P = 0.02) and in LDL fraction (mean ± S.D.; 1.61 ± 0.11 vs. 1.52 ± 0.13, respectively; P = 0.003). Increased cholesterol content in LDL was mainly due to free cholesterol. No differences were detected between the two groups in the frequency of LDL pattern A (major LDL peak > 255 Å) and pattern B (major LDL peak ≤ 255 Å). However, a higher frequency of LDL pattern B was found in NIDDM patients with low plasma total triglycerides concentrations (< 150 mg/dl) compared to the control subjects (45% vs. 7%, P = 0.02). Thus in normolipidemic patients with mild NIDDM, the major lipoprotein abnormalities were a low level of HDL cholesterol and compositional changes in LDL and VLDL + IDL fractions. Compositional abnormalities included enrichment of apo B-containing lipoproteins with cholesterol. These lipoprotein abnormalities could have atherogenic potential in patients with mild NIDDM and normolipidemia.

Original languageEnglish (US)
Pages (from-to)111-122
Number of pages12
JournalAtherosclerosis
Volume118
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

LDL Lipoproteins
Type 2 Diabetes Mellitus
Lipoproteins
Cholesterol
IDL Lipoproteins
Triglycerides
VLDL Lipoproteins
Apolipoproteins B
HDL Cholesterol
Body Mass Index

Keywords

  • Atherosclerosis
  • LDL pattern
  • Lipoproteins
  • NIDDM
  • Normolipidemia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. / Abate, Nicola; Vega, Gloria Lena; Garg, Abhimanyu; Grundy, Scott M.

In: Atherosclerosis, Vol. 118, No. 1, 1995, p. 111-122.

Research output: Contribution to journalArticle

Abate, Nicola ; Vega, Gloria Lena ; Garg, Abhimanyu ; Grundy, Scott M. / Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. In: Atherosclerosis. 1995 ; Vol. 118, No. 1. pp. 111-122.
@article{df3a1382a3cd4083b96af8435316851a,
title = "Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM",
abstract = "This study was carried out to identify and define lipoprotein abnormalities in patients with noninsulin-dependent diabetes mellitus (NIDDM) who do not have clinical elevations of cholesterol or triglycerides. Thirty-four male patients with mild NIDDM and normolipidemia (plasma cholesterol ≤ 240 mg/dl and triglycerides ≤ 250 mg/dl) were compared with 35 healthy male normolipidemic subjects. The two groups had similar age and body mass index. Measurements in the two groups included concentrations and chemical composition of lipoproteins and sizing of low-density lipoprotein (LDL) particles. The patients with NIDDM, compared to control subjects, had two distinct lipoprotein abnormalities: first, a significantly reduced level of high-density lipoprotein (HDL) cholesterol (mean ± S.D., 35 ± 8 mg/dl vs. 41 ± 10 mg/dl, respectively; P = 0.006); and second, a high cholesterol-to-apolipoprotein (apo) B ratio both in very low density lipoprotein (VLDL) + intermediate density lipoprotein (IDL) fraction (mean ± S.D.; 3.2 ± 0.8 vs. 2.8 ± 0.9, respectively; P = 0.02) and in LDL fraction (mean ± S.D.; 1.61 ± 0.11 vs. 1.52 ± 0.13, respectively; P = 0.003). Increased cholesterol content in LDL was mainly due to free cholesterol. No differences were detected between the two groups in the frequency of LDL pattern A (major LDL peak > 255 {\AA}) and pattern B (major LDL peak ≤ 255 {\AA}). However, a higher frequency of LDL pattern B was found in NIDDM patients with low plasma total triglycerides concentrations (< 150 mg/dl) compared to the control subjects (45{\%} vs. 7{\%}, P = 0.02). Thus in normolipidemic patients with mild NIDDM, the major lipoprotein abnormalities were a low level of HDL cholesterol and compositional changes in LDL and VLDL + IDL fractions. Compositional abnormalities included enrichment of apo B-containing lipoproteins with cholesterol. These lipoprotein abnormalities could have atherogenic potential in patients with mild NIDDM and normolipidemia.",
keywords = "Atherosclerosis, LDL pattern, Lipoproteins, NIDDM, Normolipidemia",
author = "Nicola Abate and Vega, {Gloria Lena} and Abhimanyu Garg and Grundy, {Scott M.}",
year = "1995",
doi = "10.1016/0021-9150(95)05597-P",
language = "English (US)",
volume = "118",
pages = "111--122",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM

AU - Abate, Nicola

AU - Vega, Gloria Lena

AU - Garg, Abhimanyu

AU - Grundy, Scott M.

PY - 1995

Y1 - 1995

N2 - This study was carried out to identify and define lipoprotein abnormalities in patients with noninsulin-dependent diabetes mellitus (NIDDM) who do not have clinical elevations of cholesterol or triglycerides. Thirty-four male patients with mild NIDDM and normolipidemia (plasma cholesterol ≤ 240 mg/dl and triglycerides ≤ 250 mg/dl) were compared with 35 healthy male normolipidemic subjects. The two groups had similar age and body mass index. Measurements in the two groups included concentrations and chemical composition of lipoproteins and sizing of low-density lipoprotein (LDL) particles. The patients with NIDDM, compared to control subjects, had two distinct lipoprotein abnormalities: first, a significantly reduced level of high-density lipoprotein (HDL) cholesterol (mean ± S.D., 35 ± 8 mg/dl vs. 41 ± 10 mg/dl, respectively; P = 0.006); and second, a high cholesterol-to-apolipoprotein (apo) B ratio both in very low density lipoprotein (VLDL) + intermediate density lipoprotein (IDL) fraction (mean ± S.D.; 3.2 ± 0.8 vs. 2.8 ± 0.9, respectively; P = 0.02) and in LDL fraction (mean ± S.D.; 1.61 ± 0.11 vs. 1.52 ± 0.13, respectively; P = 0.003). Increased cholesterol content in LDL was mainly due to free cholesterol. No differences were detected between the two groups in the frequency of LDL pattern A (major LDL peak > 255 Å) and pattern B (major LDL peak ≤ 255 Å). However, a higher frequency of LDL pattern B was found in NIDDM patients with low plasma total triglycerides concentrations (< 150 mg/dl) compared to the control subjects (45% vs. 7%, P = 0.02). Thus in normolipidemic patients with mild NIDDM, the major lipoprotein abnormalities were a low level of HDL cholesterol and compositional changes in LDL and VLDL + IDL fractions. Compositional abnormalities included enrichment of apo B-containing lipoproteins with cholesterol. These lipoprotein abnormalities could have atherogenic potential in patients with mild NIDDM and normolipidemia.

AB - This study was carried out to identify and define lipoprotein abnormalities in patients with noninsulin-dependent diabetes mellitus (NIDDM) who do not have clinical elevations of cholesterol or triglycerides. Thirty-four male patients with mild NIDDM and normolipidemia (plasma cholesterol ≤ 240 mg/dl and triglycerides ≤ 250 mg/dl) were compared with 35 healthy male normolipidemic subjects. The two groups had similar age and body mass index. Measurements in the two groups included concentrations and chemical composition of lipoproteins and sizing of low-density lipoprotein (LDL) particles. The patients with NIDDM, compared to control subjects, had two distinct lipoprotein abnormalities: first, a significantly reduced level of high-density lipoprotein (HDL) cholesterol (mean ± S.D., 35 ± 8 mg/dl vs. 41 ± 10 mg/dl, respectively; P = 0.006); and second, a high cholesterol-to-apolipoprotein (apo) B ratio both in very low density lipoprotein (VLDL) + intermediate density lipoprotein (IDL) fraction (mean ± S.D.; 3.2 ± 0.8 vs. 2.8 ± 0.9, respectively; P = 0.02) and in LDL fraction (mean ± S.D.; 1.61 ± 0.11 vs. 1.52 ± 0.13, respectively; P = 0.003). Increased cholesterol content in LDL was mainly due to free cholesterol. No differences were detected between the two groups in the frequency of LDL pattern A (major LDL peak > 255 Å) and pattern B (major LDL peak ≤ 255 Å). However, a higher frequency of LDL pattern B was found in NIDDM patients with low plasma total triglycerides concentrations (< 150 mg/dl) compared to the control subjects (45% vs. 7%, P = 0.02). Thus in normolipidemic patients with mild NIDDM, the major lipoprotein abnormalities were a low level of HDL cholesterol and compositional changes in LDL and VLDL + IDL fractions. Compositional abnormalities included enrichment of apo B-containing lipoproteins with cholesterol. These lipoprotein abnormalities could have atherogenic potential in patients with mild NIDDM and normolipidemia.

KW - Atherosclerosis

KW - LDL pattern

KW - Lipoproteins

KW - NIDDM

KW - Normolipidemia

UR - http://www.scopus.com/inward/record.url?scp=0028886350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028886350&partnerID=8YFLogxK

U2 - 10.1016/0021-9150(95)05597-P

DO - 10.1016/0021-9150(95)05597-P

M3 - Article

C2 - 8579621

AN - SCOPUS:0028886350

VL - 118

SP - 111

EP - 122

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -